Press release: The Jerome Lejeune Foundation salutes the memory of Marthe Gautier, collaborator of Jérôme Lejeune and co-signatory of the publication of the discovery of trisomy […]
The Jerome Lejeune Foundation postdoctoral fellowships program started in 2017 in partnership with the Sisley-d’Ornano Foundation with the aim of supporting the career development of promising […]
The idea that a disequilibrium between homocysteine catabolism and the production the cysteine underlies some of the alterations observed in Down syndrome (DS) was suggested by […]
Down syndrome (DS), caused by the complete or partial triplication of chromosome 21, presents a great challenge for research, medical care and development of therapies in […]
This year, the recipients of the Jerome Lejeune Young Researcher Award are two young scientists that are completing or have completed their PhD thesis on intellectual disabilities […]
Fragile X syndrome and phosphodiesterases Fragile X syndrome (FXS) is the most common form of inherited intellectual disability. It is a rare genetic neurodevelopmental disorder characterised […]
Significant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]
